Title | Diet Soda Consumption and Risk of Incident End Stage Renal Disease. |
Publication Type | Journal Article |
Year of Publication | 2017 |
Authors | Rebholz CM, Grams ME, Steffen LM, Crews DC, Anderson CAM, Bazzano LA, Coresh JJ |
Secondary Authors | Appel LJ |
Journal | Clin J Am Soc Nephrol |
Volume | 12 |
Issue | 1 |
Pagination | 79-86 |
Date Published | 2017 01 06 |
ISSN | 1555-905X |
Keywords | Beverages, Body Mass Index, Diet Records, Female, Follow-Up Studies, Humans, Incidence, Kidney Failure, Chronic, Male, Middle Aged, Obesity, Prospective Studies, Risk Factors, Sweetening Agents, United States |
Abstract | BACKGROUND AND OBJECTIVES: Diet soda consumption is common in the United States and is associated with impaired glucose metabolism, diabetes, and metabolic syndrome. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We prospectively analyzed diet soda consumption, assessed by food frequency questionnaire at baseline (1987-1989) and a follow-up examination (1993-1995), and incident ESRD through December 31, 2012 in the Atherosclerosis Risk in Communities study (n=15,368). RESULTS: Baseline mean age of participants was 54 years, 55% were female, and 27% were black. The majority of participants (43.5%) consumed 7 glasses/wk. Over a median follow-up of 23 years, 357 incident ESRD cases were observed. Relative to 7 glasses/wk, respectively, was associated with 1.08-times (95% confidence interval [95% CI], 0.75 to 1.55), 1.33-times (95% CI, 1.01 to 1.75), and 1.83-times (95% CI, 1.01 to 2.52) higher risk of ESRD after adjusting for age, sex, race-center, education level, smoking status, physical activity, total caloric intake, eGFR, body mass index category, diabetes, systolic BP, and serum uric acid (P value for trend CONCLUSIONS: Diet soda consumption was associated with higher ESRD risk in this general population sample. Further research is necessary to validate these findings in other study populations and to examine potential mechanisms through which diet soda could impact kidney disease. |
DOI | 10.2215/CJN.03390316 |
Alternate Journal | Clin J Am Soc Nephrol |
PubMed ID | 27797893 |
PubMed Central ID | PMC5220651 |
Grant List | HHSN268201100012C / HL / NHLBI NIH HHS / United States HHSN268201100009I / HL / NHLBI NIH HHS / United States HHSN268201100010C / HL / NHLBI NIH HHS / United States K23 DK097184 / DK / NIDDK NIH HHS / United States HHSN268201100008C / HL / NHLBI NIH HHS / United States HHSN268201100005G / HL / NHLBI NIH HHS / United States HHSN268201100008I / HL / NHLBI NIH HHS / United States HHSN268201100007C / HL / NHLBI NIH HHS / United States K01 DK107782 / DK / NIDDK NIH HHS / United States HHSN268201100011I / HL / NHLBI NIH HHS / United States HHSN268201100011C / HL / NHLBI NIH HHS / United States HHSN268201100006C / HL / NHLBI NIH HHS / United States P30 DK072488 / DK / NIDDK NIH HHS / United States HHSN268201100005I / HL / NHLBI NIH HHS / United States HHSN268201100009C / HL / NHLBI NIH HHS / United States HHSN268201100005C / HL / NHLBI NIH HHS / United States HHSN268201100007I / HL / NHLBI NIH HHS / United States K08 DK092287 / DK / NIDDK NIH HHS / United States |